Clinical consequences of an increasing trend of preferential use of cultured villi for molecular diagnosis by CVS

Abimbola Aina-Mumuney, Elizabeth D. Wood, Virginia L. Corson, Gail Stetten, Shama Jari, Corinne D. Boehm, Karin J. Blakemore

Research output: Research - peer-reviewArticle

Abstract

Objective: To compare the use of uncultured versus cultured villus cells for DNA-based prenatal diagnosis. Methods: A retrospective review of molecular testing of chorionic villus sampling (CVS) cases from 1988-2007. Method of analysis, gestational age (GA) at CVS and at diagnosis, time from procedure to results, results of maternal contamination studies, and the laboratory employed were abstracted from patient charts. Trends in laboratory practices over time were analyzed. Results: Time from CVS to diagnosis was longer when cultured cells were used. Average GA at diagnosis was 14-6/7 weeks with cultured cells vs 13-0/7 weeks with uncultured villi (p <0.001). Recently, laboratories are more frequently requiring cultured cells, resulting in significantly greater delays in time to diagnosis and GA at results. Conclusions: 'Direct' DNA extraction saves 2 weeks from CVS to results. More women are afforded the option of an earlier, safer pregnancy termination if uncultured villi are used for molecular diagnosis. Implementation of standardized DNA extraction protocols and sample-size requirements can optimize the use of uncultured villi for molecular prenatal diagnosis. Increased awareness of the importance of rapid results and the advantages of 'direct' DNA extraction from uncultured villi can lead to improvements that are of clinical significance for patients undergoing early prenatal diagnosis.

LanguageEnglish (US)
Pages332-334
Number of pages3
JournalPrenatal Diagnosis
Volume28
Issue number4
DOIs
StatePublished - Apr 2008

Fingerprint

Chorionic Villi Sampling
Cultured Cells
DNA
Prenatal Diagnosis
Gestational Age
Sample Size
Early Diagnosis
Mothers
Pregnancy

Keywords

  • Chorionic villus sampling
  • Cultured villi
  • Molecular diagnosis
  • Prenatal diagnosis

ASJC Scopus subject areas

  • Genetics(clinical)
  • Obstetrics and Gynecology

Cite this

Clinical consequences of an increasing trend of preferential use of cultured villi for molecular diagnosis by CVS. / Aina-Mumuney, Abimbola; Wood, Elizabeth D.; Corson, Virginia L.; Stetten, Gail; Jari, Shama; Boehm, Corinne D.; Blakemore, Karin J.

In: Prenatal Diagnosis, Vol. 28, No. 4, 04.2008, p. 332-334.

Research output: Research - peer-reviewArticle

@article{dab50c1802e6437385fde18906b9b1a7,
title = "Clinical consequences of an increasing trend of preferential use of cultured villi for molecular diagnosis by CVS",
abstract = "Objective: To compare the use of uncultured versus cultured villus cells for DNA-based prenatal diagnosis. Methods: A retrospective review of molecular testing of chorionic villus sampling (CVS) cases from 1988-2007. Method of analysis, gestational age (GA) at CVS and at diagnosis, time from procedure to results, results of maternal contamination studies, and the laboratory employed were abstracted from patient charts. Trends in laboratory practices over time were analyzed. Results: Time from CVS to diagnosis was longer when cultured cells were used. Average GA at diagnosis was 14-6/7 weeks with cultured cells vs 13-0/7 weeks with uncultured villi (p <0.001). Recently, laboratories are more frequently requiring cultured cells, resulting in significantly greater delays in time to diagnosis and GA at results. Conclusions: 'Direct' DNA extraction saves 2 weeks from CVS to results. More women are afforded the option of an earlier, safer pregnancy termination if uncultured villi are used for molecular diagnosis. Implementation of standardized DNA extraction protocols and sample-size requirements can optimize the use of uncultured villi for molecular prenatal diagnosis. Increased awareness of the importance of rapid results and the advantages of 'direct' DNA extraction from uncultured villi can lead to improvements that are of clinical significance for patients undergoing early prenatal diagnosis.",
keywords = "Chorionic villus sampling, Cultured villi, Molecular diagnosis, Prenatal diagnosis",
author = "Abimbola Aina-Mumuney and Wood, {Elizabeth D.} and Corson, {Virginia L.} and Gail Stetten and Shama Jari and Boehm, {Corinne D.} and Blakemore, {Karin J.}",
year = "2008",
month = "4",
doi = "10.1002/pd.1953",
volume = "28",
pages = "332--334",
journal = "Prenatal Diagnosis",
issn = "0197-3851",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Clinical consequences of an increasing trend of preferential use of cultured villi for molecular diagnosis by CVS

AU - Aina-Mumuney,Abimbola

AU - Wood,Elizabeth D.

AU - Corson,Virginia L.

AU - Stetten,Gail

AU - Jari,Shama

AU - Boehm,Corinne D.

AU - Blakemore,Karin J.

PY - 2008/4

Y1 - 2008/4

N2 - Objective: To compare the use of uncultured versus cultured villus cells for DNA-based prenatal diagnosis. Methods: A retrospective review of molecular testing of chorionic villus sampling (CVS) cases from 1988-2007. Method of analysis, gestational age (GA) at CVS and at diagnosis, time from procedure to results, results of maternal contamination studies, and the laboratory employed were abstracted from patient charts. Trends in laboratory practices over time were analyzed. Results: Time from CVS to diagnosis was longer when cultured cells were used. Average GA at diagnosis was 14-6/7 weeks with cultured cells vs 13-0/7 weeks with uncultured villi (p <0.001). Recently, laboratories are more frequently requiring cultured cells, resulting in significantly greater delays in time to diagnosis and GA at results. Conclusions: 'Direct' DNA extraction saves 2 weeks from CVS to results. More women are afforded the option of an earlier, safer pregnancy termination if uncultured villi are used for molecular diagnosis. Implementation of standardized DNA extraction protocols and sample-size requirements can optimize the use of uncultured villi for molecular prenatal diagnosis. Increased awareness of the importance of rapid results and the advantages of 'direct' DNA extraction from uncultured villi can lead to improvements that are of clinical significance for patients undergoing early prenatal diagnosis.

AB - Objective: To compare the use of uncultured versus cultured villus cells for DNA-based prenatal diagnosis. Methods: A retrospective review of molecular testing of chorionic villus sampling (CVS) cases from 1988-2007. Method of analysis, gestational age (GA) at CVS and at diagnosis, time from procedure to results, results of maternal contamination studies, and the laboratory employed were abstracted from patient charts. Trends in laboratory practices over time were analyzed. Results: Time from CVS to diagnosis was longer when cultured cells were used. Average GA at diagnosis was 14-6/7 weeks with cultured cells vs 13-0/7 weeks with uncultured villi (p <0.001). Recently, laboratories are more frequently requiring cultured cells, resulting in significantly greater delays in time to diagnosis and GA at results. Conclusions: 'Direct' DNA extraction saves 2 weeks from CVS to results. More women are afforded the option of an earlier, safer pregnancy termination if uncultured villi are used for molecular diagnosis. Implementation of standardized DNA extraction protocols and sample-size requirements can optimize the use of uncultured villi for molecular prenatal diagnosis. Increased awareness of the importance of rapid results and the advantages of 'direct' DNA extraction from uncultured villi can lead to improvements that are of clinical significance for patients undergoing early prenatal diagnosis.

KW - Chorionic villus sampling

KW - Cultured villi

KW - Molecular diagnosis

KW - Prenatal diagnosis

UR - http://www.scopus.com/inward/record.url?scp=42049102030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42049102030&partnerID=8YFLogxK

U2 - 10.1002/pd.1953

DO - 10.1002/pd.1953

M3 - Article

VL - 28

SP - 332

EP - 334

JO - Prenatal Diagnosis

T2 - Prenatal Diagnosis

JF - Prenatal Diagnosis

SN - 0197-3851

IS - 4

ER -